US Drug Recall Register
Class III · Low risk Terminated Initiated Jul 20, 2020 (6 years ago)

Clobetasol Propionate Cream USP

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.

What was recalled

Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For External Use Only, Not for Ophthalmic Use, Mfd by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Marketed by: Golden State Medical Supply, Inc. Camarillo, CA 93012.

Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1496-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Gold recalls

See all
Class II · Moderate risk Ongoing

Deodorant: a) Axe

Reason CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Gold Star Distribution INC D-0286-2026
Class II · Moderate risk Ongoing

Trinity Gold Nutrition

Reason Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.

Trinity Gold Nutrition D-0042-2025
Class I · High risk Ongoing

Gold Hard Steel Plus Liquid

Reason Marketed without an approved NDA/ANDA: FDA analysis found products to be tainted with undeclared acetaminophen and sildenafil.

Supercore Products Group Inc. D-0004-2025
Class II · Moderate risk Ongoing

Natural Pain Relieving Cream

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0529-2024